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Abstract
Lupus enteritis is a rare manifestation seen in systemic lupus erythematosus (SLE). Its diagnosis can be challenging as
symptoms frequently overlap many gastrointestinal disorders, imaging ﬁndings are not speciﬁc, and endoscopic features
are infrequently diagnostic. Moreover, enteritis can occur in isolation without other systemic manifestations or even
elevated inﬂammatory markers.1 Here is presented the case of a 22-year-old female with known SLE manifested by
lupus nephritis complicated by end-stage renal disease who presented with abdominal pain. She had leukocytosis with
thickened bowel loops, ascites, “target sign”, “comb sign” and patent abdominal vessels on CT imaging. The differential
diagnoses considered ranged from infectious gastroenteritis to systemic vasculitis. Her infectious workup was negative
while inﬂammatory markers and autoimmune workup did not support active lupus ﬂare. Having ruled out alternative
etiologies, steroid dosing was increased in consultation with rheumatology. Subsequently, her abdominal pain
responded supporting a diagnosis of lupus enteritis. The case was perplexing in light of her non-speciﬁc presenting
symptoms and the absence of laboratory evidence of active lupus ﬂare which delayed the diagnosis. This case illustrates
how the diagnosis of lupus enteritis continues to remain a challenge.
Keywords: Lupus enteritis, Systemic lupus erythematosus (SLE), Target sign, Steroids

1. Introduction

S

ystemic Lupus Erythematosus (SLE) is a
chronic autoimmune disease characterized by
the formation of autoantibodies. Nearly every organ
system in the body can be affected by SLE with the
most affected organ systems being the integumentary, musculoskeletal, renal, cardiovascular, hematologic, and central nervous system. Its incidence is
estimated at 23.2 cases per 100,000 persons in North
America with African American females being the
most affected group.2 The initial presentation of SLE
is widely heterogenous which can make recognition
challenging. To standardize diagnosis; the American
College of Rheumatology (ACR) devised criteria
requires 4 out of 11 parameters be met for diagnosis.
The 11 criteria are malar rash, discoid rash, photosensitivity, oral ulcers, arthritis, serositis, antinuclear antibody (ANA) and disorders of renal,
neurologic, hematologic, or immunologic systems.

This was recently revised in 2019 in conjunction
with the European League against Rheumatism
(EULAR) to produce the latest guidelines.3
Abdominal pain and other gastrointestinal complaints are frequently encountered in SLE, but these
are usually the result of infection brought on by
immunosuppression, medication side effects, or
even unrelated gastrointestinal comorbidities.4 SLErelated gastrointestinal involvement is rare, presentations range from oral ulceration, serositis,
pancreatitis, hepatobiliary manifestations to lupus
enteritis, protein-losing enteropathy, and intestinal
pseudo-obstruction.5,6 Despite advancements in the
treatment of SLE, speciﬁc diagnostic criteria for
lupus enteritis remain poorly deﬁned. We present
the case of a 22-year-old SLE patient that presented
with non-speciﬁc abdominal complaints who is
eventually diagnosed with lupus enteritis. The path
to her diagnosis was marred with diagnostic challenges and further confounded by the lack of
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inﬂammatory or autoimmune markers to suggest an
acute lupus ﬂare.

2. Case presentation
A 23-year-old African American female with a
known history of SLE complicated by end-stage
renal disease, type 2 diabetes mellitus, and psychogenic non-epileptic seizure presented to the
emergency department (ED) with a one-day history
of abdominal pain, nausea, non-bilious emesis, and
diarrhea. She noted fatigue and worsening lower
extremity swelling but denied having arthralgias,
arthritis, rashes, or ulcers. Pertinent details of her
lupus history included stage IV lupus nephritis with
current home medications of prednisone, mycophenolate mofetil, and hydroxychloroquine.
On presentation, the patient's vitals were as follows: temperature 37.0  C, blood pressure 224/
169 mmHg, heart rate 96 bpm, and respiratory rate
16/min with 100% oxygen saturation on room air.
On examination, her abdomen was mildly distended, diffusely tender to palpation with guarding,
but no rigidity or rebound tenderness. She had 2þ
pitting edema of her bilateral lower extremities. Her
laboratory results on admission (Table 1) were
notable for leukocytosis with neutrophilia, hyperkalemia, markedly elevated BUN and creatinine,
and mildly elevated procalcitonin. CT abdomen
pelvis showed diffusely dilated and thickened bowel
loops without obstruction, “target sign,” “comb

sign,” and considerable ascites without evidence of
ischemia (see Figs. 1e5).
Her hyperkalemia and markedly elevated BUN
and creatinine were the result of a recently shortened dialysis session and raised concern that uremia and incomplete dialysis could account for her
nausea, diarrhea and hypertensive urgency. She
received urgent hemodialysis for hyperkalemia of

Fig. 1. Axial view of CT abdomen with contrast showing target sign.

Table 1. Laboratory results on admission.
Labs

Day of admission

Reference

WBC
Neutrophil Total
Neutrophil %
Hemoglobin
Platelet
Sodium
Potassium
Chloride
Bicarbonate
Anion Gap
BUN
Creatinine
Glucose
Phosphate
Albumin
Total protein
Total Bilirubin
AST
ALT
ESR
CRP
Lipase
Lactic acid
Procalcitonin

12.72  10 /mL
9.44  103/mL
74.2%
13.5 g/dL
299  103/m L
135 mEq/L
5.9 mEq/L
95 mEq/L
20.6 mEq/L
19.4
75 mg/dL
11.75 mg/dL
195 mg/dL
7.8 mg/dL
4.9 g/dL
7.9 g/dL
0.4 mg/dL
15 IU/L
9 IU/L
31 mm/h
0.41 mg/dL
20.8 IU/L
1.2 mmol/L
0.16 ng/mL

4e11  103/m L
2.00e8.00  103/mL
e
12.5e15 g/dL
140e400  103/m L
133-145 mEq/L
3.3e5.1 mEq/L
96-108 mEq/L
22-29 mEq/L
5e16
6e23 mg/dL
0.5e1.00 mg/dL
70e115 mg/dL
2.6e4.5 mg/dL
3.2e5.2 g/dL
5.9e8.4 g/dL
<1.0 mg/dL
4e31 IU/L
4e31 IU/L
<20 mm/h
<0.05 mg/dL
16e63 IU/L
0.5e1.9 mmol/L
0.10 ng/mL
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Fig. 2. Axial view of CT abdomen showing comb sign.

Fig. 3. Axial view of CT abdomen showing Coomb sign.

Fig. 4. Coronal view of CT abdomen showing target sign.

A paracentesis was performed prior to the initiation of antibiotics to further characterize the patient's newly discovered ascites. Fluid analyses
showed 531 white blood cells/cumm with a 65%
lymphocytic predominance, serum ascitic albumin
gradient (SAAG) was <1.1 and gram stain and cultures were negative (Table 2).
Given the radiographic appearance of the patient's bowel with target and comb sign, lupus enteritis was considered highly likely, and
rheumatology was consulted.
Inﬂammatory markers e ESR and CRP were
minimally elevated with normal C4 levels and
borderline low C3 that were not typical of her past
active lupus ﬂares. Additional autoimmune evaluation showed high titers of ANA, elevated antidsDNA, and anti-Ro (Table 3).
CT angiography of abdomen undertaken to evaluate for mesenteric thrombosis/arteritis showed
patent intraabdominal vessels without thrombi.
Table 2. Ascitic ﬂuid analysis.
Labs
Gross appearance
Protein
Albumin
SAAG
Gram Stain
Culture
Cytology

Clear yellow
4.3 g/dL (serum protein 7.0 g/dL)
3.1 g/dL (serum albumin 4.1 g/dL)
1.0
Few PMNs, no organisms seen
No growth
Predominantly histiocytes, few mesothelial
cells, few acute and chronic inﬂammatory
cells

Table 3. Autoimmune laboratory results.
Reference
Fig. 5. Sagittal view of CT abdomen showing target sign (single arrow)
with hint of Comb sign (double arrow).

Complement C3
Complement C4
ANA titers

5.9 mEq/L and EKG ﬁndings consistent with
hyperkalemic emergency with reduction in pedal
edema but her abdominal symptoms persisted.
Diabetic ketoacidosis was entertained as a cause
of her abdominal pain, but her glucose was only
mild elevated, acetone was negative and her mild
anion gap metabolic acidosis was more easily
explained by uremia given its resolution post dialysis. The patient was placed on bowel rest and
general surgery was consulted. Surgery did not feel
that her presentation or imaging represented pathology that would require surgical intervention.
They raised the question of infectious enteritis.
Workup for an infectious etiology was negative
including Clostridioidies difﬁcile.

ANA pattern
Anti mitochondrial antibody
Anti-dsDNA
Anti-smooth muscle/RNP
(Ribonucleoprotein)
anti-Ro/SSA
Anti-La/SSB
Rheumatoid Factor
Anti-Scl (scleroderma)
Anticardiolipin antibody
IgM
IgG
IgA
Anti-beta 2 glycoprotein
IgM
IgG
Lupus anticoagulant
with reﬂex

73.3 mg/dL
29.5 mg/dL
1:320

76e100 mg/dL
15e46 mg/dL
Negative <1:40
Elevated >1:180
Nuclear homogenous pattern
Negative
1:20
<1:10
<1.0 Negative
>8.0
<1.0 Negative
<14 IU/mL
<1.0 Negative

Negative <1.0
Negative <1.0
<14 IU/mL
Negative <1.0

<2.0
<2.0
<2.0

<20.0 APL-U/mL
<20.0 APL-U/mL
<20.0 APL-U/mL

70
<9
Not detected

<20 SMU
<20 SMU
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Incidentally, it was noted that the bowel wall edema
and the volume of ascites had improved compared
to her previous imaging obtained on admission.
After ruling out most of the alternative diagnoses
with persisting nausea and abdominal pain, lupus
enteritis seemed the likely diagnosis and her prednisone dose was increased to 1 mg/kg/day with
continued improvement of abdominal pain. Further
endoscopic evaluation was deferred, and she was
discharged on a steroid taper with outpatient
rheumatology follow up where she continues to
do well.

3. Discussion
The gastrointestinal manifestations of SLE were
ﬁrst alluded to by William Osler in 1895, but it was
not until 1980, when the duo of Hoffman and Katz
succinctly described lupus enteritis.7,8 The British
Isles Lupus Assessment Group (BILAG) in 2004
deﬁned lupus enteritis as “vasculitis or inﬂammation of the small bowel, with supportive image and/
or biopsy ﬁndings”.9 The pathophysiology behind
lupus enteritis is thought to be the deposition of
immune complexes with subsequent complement
activation leading to edema in bowel wall.10 The
most involved sites are the ileum and jejunum.
Studies estimate the rates of lupus enteritis to range
from 0.2 to 5.8% among patients already diagnosed
with SLE, with a mean onset of 34 months from the
time of lupus diagnosis.4 In addition, isolated presentations of lupus enteritis as the initial presentation of SLE have been described.11,12 Koo et al. in
their retrospective review of radiographically
conﬁrmed lupus enteritis found an 85% female
prevalence and a median age of 34 years.13 The
initial presenting signs and symptoms of abdominal
pain, nausea, vomiting, anorexia, and diarrhea are
commonplace and may not elicit clinical suspicion.
Additionally, ongoing immunosuppressive treatment can mask gastrointestinal (GI) symptoms.
Zizic et al. in their retrospective review of 140 SLE
patients found the presence of vasculitis, thrombocytopenia, or rheumatoid factor to be associated
with an increased risk of developing lupus enteritis,
all of which were absent in our patient.14 In the
medical literature, lupus nephritis has been strongly
associated with lupus enteritis with an estimated
65% co-existence such as in our patient.15,1
Laboratory testing is valuable in supporting a
diagnosis of lupus enteritis. The levels of inﬂammatory markers are variable, but CRP is frequently
normal and complement levels are usually low in
70% of cases.15 Autoantibodies are more reliable,
with ANA titers elevated in 92%, positive anti-

dsDNA in 80% and 20% seropositivity for anti-smith
antibodies.10 While, our patient did have elevated
titers of ANA and anti-dsDNA with normal CRP,
her complement titers were not low as her past
typical lupus ﬂares had. Luis et al. noted similar
ﬁndings of non-elevated ESR and CRP with
modestly elevated anti-dsDNA titers in their retrospective analysis of 7 patients with lupus enteritis.1
These autoimmune and inﬂammatory markers can
be helpful but, are not a requirement for diagnosis
as isolated lupus enteritis can occur without clinically active lupus as was seen in this case.15
Unfortunately; the criteria for lupus enteritis has
not been deﬁned by ACR and past attempts to
produce normograms or predictive models have
yielded conﬂicting results.
Liu and colleagues produced a normogram consisting of 11 features to help predict lupus enteritis,
these are; age, albumin, anion gap, D-dimer, platelet
count, ANCA, C4, anti-SSA (Sjogren syndromerelated antigen A), anti-ribosomal P protein (Rib-P),
anti-ribonucleoprotein (RNP).16 The last four variables had the strongest correlation with C4 being a
protective factor while anti-SSA, anti-Rib-P and
anti-RNP were risk factors with anti-RNP being the
strongest risk factor.16 Our patient only had 1 of 11
predictive markers and that was anti-SSA.
Conversely, Zhang and colleagues’ predictive normogram for diagnosis of LE found elevated Ddimer, low C3 and anti-SSA to be positively predictive.17 Similarly, Lee et al. in their retrospective
review of 175 SLE patients categorized into lupus
enteritis (n ¼ 17), non LE related abdominal pain
and SLE without abdominal pain only found
leukopenia to correlate with occurrence of lupus
enteritis.18 They did not ﬁnd SLE Disease Activity
Index (SLEDAI) or other laboratory parameters
including complement, ESR, CRP, lupus related
antibodies or antiphospholipid antibodies to correlate with risk of lupus enteritis.18 Comparable results were obtained by Kwok and colleagues in their
retrospective review of 87 SLE patients with
abdominal pain including lupus enteritis (n ¼ 41)
found SLEDAI and anti-endothelial cell antibody to
be signiﬁcantly higher in patients with LE.19 They
did not ﬁnd a signiﬁcant correlation with other
laboratory parameters except pre-existing antiphospholipid syndrome which increased risk of
recurrent LE.
With such discrepant ﬁndings computed tomography (CT), the imaging modality of choice has
become increasingly helpful. The classic ﬁnding of
target and comb signs are frequently seen as
described by Byun and colleagues in their retrospective review of 39 abdominal CT imaging of SLE

patients.20 Target sign occurs as a result of bowel
edema while comb sign results from engorgement
of small bowel vessels.4 Unfortunately, these image
ﬁndings are not exclusive to lupus enteritis as the
target sign can be seen in mesenteric vein thrombosis, inﬂammatory bowel disease (IBD) and bowel
ischemia. Our patient had no thrombus on CT
angiography of abdomen, bowel ischemia was
highly unlikely in the absence of hematochezia and
IBD was not entertained given acute nature of
diarrhea. Other commonly encountered imaging
patterns include ascites and mesenteric fat stranding.1 Pathology in lupus enteritis is of low yield and
frequently not diagnostic, therefore endoscopy is
not a requirement for diagnosis and mostly reserved
for cases where the diagnosis remains uncertain.15
Janssens et al. in their systematic review of 150 cases
of lupus enteritis revealed endoscopy was only
carried out in 34 cases with macroscopic ﬁndings of
bowel edema, hyperemia, and ischemia with or
without ulceration or necrosis. Microscopic ﬁndings
from endoscopically or surgically obtained tissue
revealed cellular inﬁltration of submucosa and
muscular layers, hemorrhage with occasional
vasculitis.15 We did consider enteroscopy for our
patient but deferred, as endoscopy was unlikely to
change management. Alternative diagnoses were
considered unlikely, and the patient was exhibiting
both clinical and radiological improvement with
time and steroids (see Figs. 1e5).
The treatment of choice for lupus enteritis is
immunosuppression with steroids. The optimum
dose, route of administration, and duration of steroids vary based on the severity of presentation.
When diagnosed early, lupus enteritis responds
well to immunosuppression with symptoms
resolving rapidly upon steroid initiation, but some
may show a poor response in which case additional
immunosuppressive agents such as mycophenolate
and cyclophosphamide have been utilized with
beneﬁt.1 Early diagnosis saves patients the burden
of invasive workup. Late diagnosis has the potential
to be catastrophic with estimated mortality rates
of 11% in SLE-related acute abdominal pain6.
Untreated lupus enteritis can progress to bowel
ischemia,
infarction,
bleeding,
and
even
perforation.20
Prognosis is good when the diagnosis is made
early and high dose steroids are started in a timely
manner but occasionally patients may have a
recurrence. A recurrence rate of 28% was reported
by Koo and colleagues with higher recurrence seen
with colon or urinary tract involvement deﬁned by
contrast enhancement and wall thickening on CT
imaging.13
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4. Conclusion
Lupus enteritis should be considered among the
top differentials when SLE patients present with
non-speciﬁc abdominal complaints. A high index of
suspicion is required as there are no pathonognomic clinical features, laboratory markers, or imaging ﬁndings and endoscopy is frequently nondiagnostic.

Acknowledgment
This research received no speciﬁc grant from any
funding agency in the public, commercial, or notfor-proﬁt sectors.
Conﬂict of interest
The authors have no potential conﬂict of interest
to declare.

References
1. Luís M, Brites AL, Duarte AC, et al. How to diagnose lupus
enteritis early? Lessons learned from a multicenter case series. How to diagnose lupus enteritis early? Lessons learned
from a multicenter case series. Acta Reumatol Port. 2019;44(2):
145e150.
2. Kiriakidou M, Ching CL. Systemic Lupus Erythematosus. Ann
Intern Med. 2020;172(11):ITC81eITC96. https://doi.org/10.
7326/AITC202006020.
3. Aringer M, Costenbader K, Daikh D, et al. European League
against rheumatism/American College of rheumatology
classiﬁcation criteria for systemic lupus erythematosus.
Arthritis Rheumatol. 2019;71(9):1400e1412. https://doi.org/10.
1002/art.40930, 2019.
4. Brewer BN, Kamen DL. Gastrointestinal and hepatic disease
in systemic lupus erythematosus. Rheum Dis Clin N Am. 2018;
44(1):165e175. https://doi.org/10.1016/j.rdc.2017.09.011.
5. Ebert EC, Hagspiel KD. Gastrointestinal and hepatic manifestations of systemic lupus erythematosus. J Clin Gastroenterol. 2011;45(5):436e441. https://doi.org/10.1097/MCG.
0b013e31820f81b8.
6. Sultan SM, Ioannou Y, Isenberg DA. A review of gastrointestinal manifestations of systemic lupus erythematosus.
Rheumatology. 1999;38(10):917e932. https://doi.org/10.1093/
rheumatology/38.10.917.
7. Bert J, Gertner E. Lupus gastrointestinal tract vasculopathy:
lupus "enteritis" involving the entire gastrointestinal tract from
esophagus to rectum. Case Rep Gastroenterol. 2017;11(1):48e53.
https://doi.org/10.1159/000455826. Published 2017 Jan 31.
8. Hoffman BI, Katz WA. The gastrointestinal manifestations of
systemic lupus erythematosus: a review of the literature.
Semin Arthritis Rheum. 1980;9(4):237e247. https://doi.org/10.
1016/0049-0172(80)90016-5.
9. Isenberg DA, Rahman A, Allen E, et al. BILAG 2004. Development and initial validation of an updated version of the
British Isles Lupus Assessment Group's disease activity index
for patients with systemic lupus erythematosus. Rheumatology. 2005;44(7):902e906. https://doi.org/10.1093/rheumatology/keh624.
10. Smith LW, Petri M. Lupus enteritis: an uncommon manifestation of systemic lupus erythematosus. J Clin Rheumatol. 2013;
19(2):84e86. https://doi.org/10.1097/RHU.0b013e318284794e.
11. Bellou AM, B€
os D, Kukuk G, Gembruch U, Merz WM. Enteritis as initial manifestation of systemic lupus

CASE REPORT

JOURNAL OF COMMUNITY HOSPITAL INTERNAL MEDICINE PERSPECTIVES 2022;12:73e78

78

CASE REPORT

12.

13.

14.

15.

JOURNAL OF COMMUNITY HOSPITAL INTERNAL MEDICINE PERSPECTIVES 2022;12:73e78

erythematosus in early pregnancy: a case report [published
correction appears in Medicine (Baltimore). Medicine (Baltim).
2018
May;97(21),
e10797.
https://doi.org/10.1097/MD.
0000000000010401, 2018;97(17):e0401.
Gonzalez A, Wadhwa V, Salomon F, Kaur J, Castro FJ. Lupus
enteritis as the only active manifestation of systemic lupus
erythematosus: a case report. World J Clin Cases. 2019;7(11):
1315e1322. https://doi.org/10.12998/wjcc.v7.i11.1315.
Koo BS, Hong S, Kim YJ, Kim YG, Lee CK, Yoo B. Lupus
enteritis: clinical characteristics and predictive factors for
recurrence. Lupus. 2015;24(6):628e632. https://doi.org/10.1177/
0961203314558858.
Zizic TM, Classen JN, Stevens MB. Acute abdominal complications of systemic lupus erythematosus and polyarteritis
nodosa. Am J Med. 1982;73(4):525e531. https://doi.org/10.1016/
0002-9343(82)90331-x.
Janssens P, Arnaud L, Galicier L, et al. Lupus enteritis: from
clinical ﬁndings to therapeutic management. Orphanet J Rare
Dis. 2013;8:67. https://doi.org/10.1186/1750-1172-8-67. Published 2013 May 3.

16. Liu Z, Guo M, Cai Y, Zhao Y, Zeng F, Liu Y. A nomogram to
predict the risk of lupus enteritis in systemic lupus erythematosus patients with gastroinctestinal involvement. EClin
Med. 2021;36, 100900. https://doi.org/10.1016/j.eclinm.2021.
100900. Published 2021 May 24.
17. Zhang W, Huang G, Lin J, et al. Predictive model of risk and
severity of enteritis in systemic lupus erythematosus. Lupus. 2022;
31(10):1226e1236. https://doi.org/10.1177/09612033221110743.
18. Lee CK, Ahn MS, Lee EY, et al. Acute abdominal pain in
systemic lupus erythematosus: focus on lupus enteritis
(gastrointestinal vasculitis). Ann Rheum Dis. 2002;61(6):
547e550. https://doi.org/10.1136/ard.61.6.547.
19. Kwok SK, Seo SH, Ju JH, et al. Lupus enteritis: clinical characteristics, risk factor for relapse and association with antiendothelial cell antibody. Lupus. 2007;16(10):803e809. https://
doi.org/10.1177/0961203307082383.
20. Byun JY, Ha HK, Yu SY, et al. CT features of systemic lupus
erythematosus in patients with acute abdominal pain:
emphasis on ischemic bowel disease. Radiology. 1999;211(1):
203e209. https://doi.org/10.1148/radiology.211.1.r99mr17203.

